Wilson Sonsini advised Chroma Medicine on the deal. Genomic medicine company Chroma Medicine announced that it had completed a $135 million Series B financing, which was...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini and Honigman advised Prime Medicine on the deal, while Davis Polk advised the joint book-running managers. Prime Medicine, Inc., a biotechnology company committed to...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Totient on the deal. AbSci, the synthetic biology company unlocking the potential of proteins as next-generation therapeutics, announced the acquisition...
You must be a Standard 1 Year member to access this content.
